TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design

Philippe Nuyens; Ole De Backer; Janarthanan Sathananthan; Troels Højsgaard Jørgensen; Hendrik Treede; Jonathon A Leipsic; Jeroen J Bax; John G Webb; Roxana Mehran; Mao Chen; Michael Reardon; Martin B Leon; Lars Søndergaard

doi:10.1016/j.jcin.2023.04.003

TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design

JACC Cardiovasc Interv. 2023 Jul 10;16(13):1682-1687. doi: 10.1016/j.jcin.2023.04.003.

Authors

Affiliations

¹ The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
² St. Paul's Hospital, Vancouver, British Columbia, Canada; Centre for Cardiovascular and Heart Valve Innovation, Vancouver, British Columbia, Canada.
³ Department of Cardiac and Vascular Surgery, Mainz University Hospital, Mainz, Germany.
⁴ St. Paul's Hospital, Vancouver, British Columbia, Canada.
⁵ Leiden University Medical Center, Leiden, the Netherlands.
⁶ Mount Sinai, New York, New York, USA.
⁷ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
⁸ DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, USA.
⁹ Columbia Interventional Cardiovascular Care, Columbia University Medical Center, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA.
¹⁰ The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: lars.soendergaard.01@regionh.dk.

PMID: 37438037
DOI: 10.1016/j.jcin.2023.04.003

No abstract available

Keywords: aortic valve stenosis; bicuspid aortic valve; randomized controlled trial; surgical aortic valve replacement; transcatheter aortic valve replacement.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Randomized Controlled Trials as Topic
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome